Benzinga | Jan 5, 2022 10:45AM EST

Oppenheimer Maintains Outperform on icad, Lowers Price Target to $16

Oppenheimer analyst Francois Brisebois maintains icad (NASDAQ:ICAD) with a Outperform and lowers the price target from $22 to $16.